Patient navigator
Runs the daily worklist, records care barriers per Law 14.758, updates tasks, advances the phase when there is evidence and closes the journey with a formal reason. This is who the module serves first.
Module · Cancer Patient Navigation
Brazilian Federal Law 14.758/2023 instrumented — from triage to surveillance.
Built so the patient navigator can follow the patient journey with the statutory deadline, categorized care barriers and an append-only audit log. Active compliance with Brazilian Federal Law 14.758/2023 (Brazilian National Cancer Prevention and Control Policy), Brazilian Federal Law 12.732/2012 (60-day rule from diagnosis to treatment start) and LGPD (Brazil's General Data Protection Law) art. 11.
Personas served
Who operates Cancer Patient Navigation.
Law 14.758/2023 formalizes the patient navigator as a dedicated professional. The module is designed around that role, with support for coordination, audit, and the medical and epidemiology teams.
Navigation coordinator
Distributes load across navigators, monitors backlog, flags statutory-deadline overruns and reviews top barriers by category for institutional action.
Oncologist
Confirms critical transitions (diagnosis → staging, treatment → surveillance) and records the closure reason. Does not run the worklist; acts as validator.
Epidemiology and quality
Exports RAS-DATASUS reporting (Brazil's public health datalake) with k-anonymity ≥ 5, audits the statutory deadline and frequent barriers, and tracks institutional KPIs tied to the National Oncology Care Policy.
Phase-based journey
Seven canonical phases, validated transitions.
Every patient has a current phase. Transitions are validated (never silent) and history is append-only — nothing is lost, nothing is overwritten. The wording below matches the product worklist's Filter by phase control verbatim.
-
01
Triage
Initial identification of a patient with suspected cancer and journey opening. First pull of EHR data, provisional ICD code, start of the Law 12.732/2012 countdown.
-
02
Diagnosis
Confirmatory tests, biopsy, definition of the histologic type (ICD-O-3). This is where the statutory deadline (60 days to treatment start) is usually under the most pressure.
-
03
Staging
Disease characterization (T, N, M; stages I–IV), complementary imaging, definition of the treatment line and handoff to the Scheduling module.
-
04
Treatment
Protocol delivery (curative, palliative, adjuvant, neoadjuvant). Connects with the Chemotherapy Scheduling module. Concurrent radiation therapy is visible to the navigator.
-
05
Surveillance
Follow-up after curative treatment. Routine visits, periodic imaging, early flagging of recurrence. The statutory deadline does not apply here (already past the initial window).
-
06
Palliative
Alternative line of care when curative intent is no longer feasible. Not an endpoint — continuity focused on quality of life, symptoms and support. A phase of its own, not a branch of "Treatment".
-
07
Closed
Formal exit from the journey with a reason (cure, death, transfer, dropout). Append-only history preserves everything — auditors can review the full trajectory after closure.
Key capabilities
What the module delivers.
Prioritized worklist
Live queue with columns Record · Patient · Phase · Status · Diagnosis · 12.732 deadline · Barriers · Overdue tasks · Navigator. Native filter by phase.
Law 12.732 countdown
The 12.732 deadline column shows days remaining to the statutory limit per patient. Semantic colors scale from green to red as the window narrows.
Validated transitions
Every phase change requires confirmation (with a reason when applicable). There are no silent transitions; the history stays immutable.
Categorized care barriers
Access, Social, Financial, Clinical, Geographic — per operational practice aligned with Law 14.758. Each barrier has an opening date, owner and status.
Append-only tasks and notes
Operational tasks with deadlines and overdue tasks highlighted in the worklist. Follow-up notes are immutable — corrections are added as new notes.
Reasoned closure
Exiting the journey requires a reason (cure, death, transfer, dropout). There is no "discharge without record". The final phase is Closed.
RAS-DATASUS export
Anonymized epidemiology report with k-anonymity ≥ 5 — suppresses cells with too few patients to prevent re-identification by cross-referencing (LGPD art. 13).
Patient registry
The /navegacao/pacientes/ screen with Record · Name · Date of birth · City/State · ICD · Linked appointments. Patient search, new patient, and automatic link to the Scheduling module.
Care barriers (Law 14.758)
Five operational categories for structured tracking.
Law 14.758/2023 acknowledges that cancer patients face non-clinical obstacles that affect outcomes. The module structures that record so patterns and institutional action become visible.
Category
Access
Distance to the unit, transportation, difficulty arriving on the right day/time, schedules dependent on third parties.
Category
Social
Family support, isolation, education level, support network, care for dependents during treatment.
Category
Financial
Cost of treatment, health plan coverage, travel, lost income, medications not covered.
Category
Clinical
Comorbidities, advanced age, performance status, contraindications, pending exams that block treatment.
Category
Geographic
Distant city of residence, dependence on social transportation, intercity travel, regional/SUS coverage.
KPIs
What coordination and audit see.
Statutory deadline
Median time diagnosis → D1
Median days between confirmed diagnosis and the first treatment cycle. Institutional comparison vs. the Law 12.732/2012 limit.
Statutory deadline
% within statutory window (60d)
Patients who started treatment within the Law 12.732 window. Sliced by month, treatment line and responsible navigator.
Operational
Top barriers by category
Distribution of active barriers across Access, Social, Financial, Clinical and Geographic. Informs institutional decisions about the support network.
Operational
Backlog per navigator
Active patients per navigator, with overload flags. Coordination redistributes load before the statutory deadline runs out.
Quality
Pending transitions
Transitions requested more than N days ago without clinical confirmation. Visible to coordination and audit.
Surveillance
Patients per phase
Current distribution across the 7 phases (Triage, Diagnosis, Staging, Treatment, Surveillance, Palliative, Closed). Sliced by month and team.
Integrations & compliance
How the module talks and what it covers.
For the full standards map, see the Methodology page. Here we cover only what is specific to this module.
HL7 FHIR R4
Relevant resources: Patient, Encounter, ServiceRequest, Observation, Task. Adopted incrementally per integration scenario.
RAS-DATASUS export
Anonymized epidemiology report, k-anonymity ≥ 5, automatically suppressing cells with too few patients (LGPD art. 13).
REST API + webhooks
Events for phase transitions, barrier opening and reasoned closure. Useful for institutional BI, alerts to support teams and real-time KPIs.
Classifications
ICD-10 and ICD-O-3 native. SNOMED CT and LOINC adopted gradually as integration demand emerges.
| Standard / requirement | How the module covers it | Where in the product |
|---|---|---|
| Brazilian Federal Law 14.758/2023 Brazilian National Cancer Prevention and Control Policy; Cancer Patient Navigation formalized (art. 5). |
Prioritized navigator worklist, 7-phase validated journey, categorized care barriers, reasoned closure. | Worklist · Journey · Barriers |
| Brazilian Federal Law 12.732/2012 60-day window between diagnosis and treatment start (art. 2). |
12.732 deadline column with countdown, alerts in the critical windows, barrier record on overrun. | Native worklist column |
| LGPD — art. 11 and 13 | Append-only audit log for every sensitive data point; anonymized export with k-anonymity ≥ 5. | Audit · RAS-DATASUS export |
Guided walkthrough of the Cancer Patient Navigation module.
In a session tailored to your setting, we walk through the navigator worklist, the Law 12.732 countdown, the care barrier record and the RAS-DATASUS export — on top of synthetic data.